U.S. IVD And LDT For Autoimmune Diseases Market (2025 - 2030) Size, Share & Trends Analysis Report By Type, By Technology (Immunoassays, Clinical Chemistry, Molecular Diagnostics), By Application (Psoriasis, Crohn’s Disease), And Segment Forecasts

Market Segmentation

• U.S. IVD & LDT For Autoimmune Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
  • IVD
    • IVD by Technology Outlook (Revenue, USD Million, 2018 - 2030)
      • Immunoassays
      • Clinical Chemistry
      • Hematology
      • Coagulation
      • Microbiology
      • Molecular Diagnostics
      • Others
    • IVD by Application Outlook (Revenue, USD Million, 2018 - 2030)
      • Addison’s Disease
      • Ankylosing Spondylitis
      • Alopecia Areata
      • Rheumatoid Arthritis
      • Systemic Lupus Erythematosus
      • Systemic Sclerosis
      • Psoriasis
      • Antiphospholipid Antibody Syndrome
      • Diabetes Type 1
      • Crohn’s Disease
      • Ulcerative Colitis
      • Narcolepsy
      • Multiple Sclerosis
      • Uveitis
      • Others
  • LDT
    • LDT by Technology Outlook (Revenue, USD Million, 2018 - 2030)
      • Immunoassays
      • Clinical Chemistry
      • Hematology
      • Coagulation
      • Microbiology
      • Molecular Diagnostics
      • Others
    • LDT by Application Outlook (Revenue, USD Million, 2018 - 2030)
      • Addison’s Disease
      • Ankylosing Spondylitis
      • Alopecia Areata
      • Rheumatoid Arthritis
      • Systemic Lupus Erythematosus
      • Systemic Sclerosis
      • Psoriasis
      • Antiphospholipid Antibody Syndrome
      • Diabetes Type 1
      • Crohn’s Disease
      • Ulcerative Colitis
      • Narcolepsy
      • Multiple Sclerosis
      • Uveitis
      • Others
• U.S. IVD & LDT For Autoimmune Disease Technology Outlook (Revenue, USD Million, 2018 - 2030)
  • Immunoassays
  • Clinical Chemistry
  • Hematology
  • Coagulation
  • Microbiology
  • Molecular Diagnostics
  • Others
• U.S. IVD & LDT For Autoimmune Disease Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Addison’s Disease
  • Ankylosing Spondylitis
  • Alopecia Areata
  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus
  • Systemic Sclerosis
  • Psoriasis
  • Antiphospholipid Antibody Syndrome
  • Diabetes Type 1
  • Crohn’s Disease
  • Ulcerative Colitis
  • Narcolepsy
  • Multiple Sclerosis
  • Uveitis
  • Others

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2018 to 2030
• Market estimates and forecast for product segments up to 2030
• Country market size and forecast for product segments up to 2030
• Market estimates and forecast for application segments up to 2030
• Country market size and forecast for application segments up to 2030
• Company financial performance